Home | Welcome to Contract Pharma   
Last Updated Friday, March 27 2015


Topics - Drug Discovery

Refine by Date:
From: To:
Published March 26, 2015
Evotec will screen several ion channel targets Read More »
Published March 25, 2015
Will receive as much as £652,000 to expand bioproduction research Read More »
Published March 17, 2015
Clinicians continue to find potential therapeutic indications for Schedule I drug substances Read More »
Published March 17, 2015
Strengthens its T cell receptor cancer gene therapy platform Read More »
Published March 13, 2015
Collaboration related to microbiome discovery and development Read More »
Published March 5, 2015
To provide integrated offering for candidate selection through to early stage trials Read More »
Published February 27, 2015
Goal is to identify best-in-class RORγ inhibitors to treat autoimmune disease Read More »
Published February 25, 2015
Opens newly expanded office Read More »
Published February 20, 2015
To use TBK1 to study ALS disease mechanisms and screen for drug candidates Read More »
Published February 18, 2015
Calias responsible for ERT programs and driving scientific and strategic direction Read More »
Published February 17, 2015
Will house commercial, corporate analytics, and business development staff Read More »
Published February 13, 2015
Expands translational oncology drug discovery services Read More »
Published February 12, 2015
Jayaraman and Kemmerling take on Discovery and Preclinical roles Read More »
Published February 6, 2015
To generate bispecific molecules against multiple targets Read More »
Published February 3, 2015
Foehr brings more than 20 years of pharma experience Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On